Extract to table

B below and represents a compliance deficiency that must be remediated either prior to or following the closing of the Transaction

These requirements are distinct from federal EPA and FDA regulations and must be independently satisfied

While enforcement practices in this area vary significantly by state, and the risk of immediate or aggressive enforcement action appears low based on current regulatory trends, the gap nonetheless represents a meaningful compliance deficiency that must be remediated

The litigation and regulatory compliance schedules — including the schedules that will list all pending and threatened litigation, government investigations, product liability claims, and regulatory filings — must be reviewed upon receipt